Gufic BioSciences share price
You have to be logged in to add this to Watchlist.- ₹345.20(-0.68%)December 12, 2025 15:29:42 PM IST
- NSE
- BSE
- Vol : 45.18 K (NSE + BSE)Last 20 day avg : 95.50 K
Gufic BioSciences is trading -0.68% lower at Rs 345.20 as compared to its last closing price. Gufic BioSciences has been trading in the price range of 351.20 & 343.75. Gufic BioSciences has given -23.75% in this year & -3.07% in the last 5 days. Gufic BioSciences has TTM P/E ratio 62.42 as compared to the sector P/E of 25.61.The company posted a net profit of 16.82 Crores in its last quarter.Listed peers of Gufic BioSciences include Divi's Laboratories (-0.27%), Dr Reddy's Laboratories (0.51%), Cipla (0.20%).The Mutual Fund holding in Gufic BioSciences was at 3.48% in 30 Sep 2025. The MF holding has increased from the last quarter. The FII holding in Gufic BioSciences was at 0.33% in 30 Sep 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Dec 14, 2025, 11:52 AM UTC
- BetaLow volatility0.70Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.56The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.03Annual dividends as a percentage of the stock price.
- P/BLower than historical values5.79The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values61.14Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation-5.51The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Bullish | 6,414.50 | -0.27 | 1,70,282.17 | 78.27 | 11.47 | 0.46 | 0.01 |
| Dr Reddy's Laboratories | Bullish | 1,279.50 | 0.51 | 1,06,784.78 | 18.80 | 3.17 | 0.63 | 2.34 |
| Cipla | Neutral | 1,515.15 | 0.20 | 1,22,397.55 | 23.33 | 3.94 | 0.85 | 0.81 |
| Sun Pharmaceutical Industries | Bullish | 1,794.50 | -0.69 | 4,30,478.68 | 37.94 | 6.04 | 0.88 | 0.50 |
| Torrent Pharmaceuticals | Bullish | 3,780.00 | -0.56 | 1,27,870.05 | 66.64 | 16.92 | 0.84 | 17.62 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-14 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-30 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results & Others |
| 2024-11-14 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE742B01025
- BSE Code509079
- NSE CodeGUFICBIO
Gufic BioSciences is trading at 345.20 as on Fri Dec 12 2025 09:59:42. This is -0.68% lower as compared to its previous closing price of 347.55.
The market capitalization of Gufic BioSciences is 3459.27 Cr as on Fri Dec 12 2025 09:59:42.
The 52 wk high for Gufic BioSciences is 497.75 whereas the 52 wk low is 285.00
Gufic BioSciences can be analyzed on the following key metrics -
- TTM P/E: 62.42
- Sector P/E: 25.61
- Dividend Yield: 0.03%
- D/E ratio: 0.58
Gufic BioSciences reported a net profit of 69.65 Cr in 2025.
The Mutual Fund Shareholding was 3.48% at the end of 30 Sep 2025.
EQUITY QUICK LINKS
Gufic BioSciences QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.